Come up with a name for your new list and we'll add to it:
Redwood Bioscience raised a round of funding on April 22, 2013. Investors include
National Science Foundation.
Redwood Bioscience is developing SMARTag technology, a precision-protein chemical engineering platform, to produce the next generation of antibody-drug conjugates and other semi-synthetic biotherapeut…